KAT Innovation develops and markets cutting-edge technologies to address unmet healthcare needs. Founded out of a genuine passion for innovation, KAT Innovation is dedicated to designing and realizing new technologies that can change lives. Marcel Maroist, the company’s CEO, and founder is a dynamic and committed entrepreneur with extensive experience in health, fitness, and sports.

His expertise has enabled him to assemble a multidisciplinary team of seasoned professionals. KAT Innovation aspires to lead the medical and healthcare technology industry, offering a range of advanced solutions that enhance health outcomes and streamline the work of medical professionals, with a particular focus on osteoporosis treatment.

KAT Innovation's flagship project is the OSTAAT™ medical device, which provides a new, effective treatment with no side effects, addressing unmet medical needs. To design a connected, effective, and state-of-the-art device, KAT Innovation prioritizes international collaboration. Since its inception, the company has expanded globally, establishing KAT Innovation Canada (Montreal), KAT Innovation France (Poitiers), KAT Innovation Technologies Spain (Malaga), and soon KAT Innovation USA (Los Angeles).

At KAT Innovation, our mission is to revolutionize bone health by creating advanced medical devices to prevent and treat fractures from osteopenia, osteoporosis, and related conditions. We are dedicated to improving quality of life through innovative, safe, and accessible medical solutions.

KAT Innovation aspires to become the global leader in the prevention and treatment of bone fractures, regardless of their origin. Our goal is to improve patients' daily lives by offering innovative solutions for better bone health.

Marcel Maroist, CEO, and founder of KAT Innovation, brings over four decades of extensive experience in corporate management and event organization across diverse sectors. His career began with ownership of a paramedical clinic in Quebec City, followed by management of a sports medicine center in Montreal's North Shore. Passionate about physical activity and health, Marcel has practiced martial arts since age 12, achieving the prestigious rank of 8th-degree black belt Taekwondo Grandmaster and establishing more than fifteen Taekwondo schools globally.

With a background in physical education and a profound commitment to sports and health, Marcel devoted over 13 years to health research, leading and funding the development of medical devices and overseeing clinical trials. His expertise spans from research and development to the commercialization of innovative healthcare solutions. Marcel's leadership in the healthcare sector has been pivotal, playing significant roles in various companies and collaborating with esteemed medical professionals both domestically and internationally.

Since 2011, Marcel has integrated his medical research expertise with martial arts principles of resilience, perseverance, and tenacity. Alongside his professional endeavors, he maintains a fervent enthusiasm for sports and health. As a visionary, Marcel founded KAT Innovation to revolutionize healthcare with patented, scientifically proven products and services, aimed at enhancing global wellness.

Today, he leads KAT Innovation with a strong commitment to innovation in healthcare and achieving excellence in management, exerting influence across North America, Europe, and Asia.

Our multidisciplinary team brings together experts from various backgrounds, including electrical and biomedical engineers, kinesiologists, physiologists, and biologists, all under the enlightened leadership of our CEO-Founder and supported by our scientific advisors. This strategic combination of skills ensures a strong position on the path to success.

For nearly 4 years, we have had the privilege of collaborating with distinguished scientific advisors, including physicians, both in Quebec and abroad.

The list of physicians and hospitals eager to participate in our project is impressive: rheumatologists, orthopedists, geriatricians, and nephrologists from prestigious institutions such as the University of Montreal Health Centre (CHUM), CHU of Bordeaux, Limoges, and Poitiers in France, University Hospitals of Malaga and Granada in Spain, Mongi Slim Hospital in Tunis, and the Osteoporosis Medical Center in Los Angeles (UCLA Health-Cedars Sinai Hospital).

These experts play a crucial role in guiding and advising us, significantly contributing to all phases of our studies, from pilot studies to preclinical animal studies, including a multicenter study involving this extensive international team of physicians.

THANKS TO THE CONTRIBUTIONS OF OUR INTERNS

Sustainability is a fundamental principle ingrained across OSTAAT™'s design and operations. We aim to deliver world-class osteoporosis therapy while minimizing environmental impact through the following initiatives:

SDG 3 – Good Health and Wellbeing: OSTAAT™ transforms bone health for osteoporosis patients globally, enhancing patient outcomes through rigorous monitoring and continuous improvement.

SDG 5 – Gender Equality: By addressing the high incidence of osteoporosis in women, OSTAAT™ empowers women to manage their bone health, promoting mobility, independence, and participation in social and economic activities.

SDG 8 – Decent Work and Economic Growth: Our growth fosters job creation and sustainable economic development, supporting equitable employment opportunities.

SDG 9 – Industry, Innovation, and Infrastructure: Through continuous innovation and inclusive partnerships, OSTAAT™ advances patient-centric osteoporosis care, shaping the future of health technologies.

We would like to extend our warmest thanks to our partners, who contribute to the success of our company. Thank you for your involvement, dedication and invaluable collaboration. We look forward to working with you for many years to come!

CANADA

SPAIN

FRANCE

UNITED STATES

TAIWAN